Hypothyroidism: Difference between revisions

Jump to navigation Jump to search
Mmir (talk | contribs)
Mmir (talk | contribs)
Line 31: Line 31:
* Congenital hypothyroidism
* Congenital hypothyroidism
* Autoimmune (Hashimoto's) thyroiditis
* Autoimmune (Hashimoto's) thyroiditis
* Resistance to TSH
|
|
* Thyroidectomy
* Thyroidectomy
Line 54: Line 55:
* Postpartum thyroiditis
* Postpartum thyroiditis
|
|
* Major suegeries
|
|
*
|-
|-
| rowspan="2" |Central Hypothyroidism
| rowspan="2" |Central Hypothyroidism
Line 156: Line 159:
! colspan="2" rowspan="2" style="background:#DCDCDC;" |Disease
! colspan="2" rowspan="2" style="background:#DCDCDC;" |Disease
! colspan="5" align="center" style="background:#DCDCDC;" |History and symptoms
! colspan="5" align="center" style="background:#DCDCDC;" |History and symptoms
! colspan="8" align="center" style="background:#DCDCDC;" |Laboratory findings
! colspan="7" align="center" style="background:#DCDCDC;" |Laboratory findings
! rowspan="2" align="center" style="background:#DCDCDC;" |Additional findings
! rowspan="2" align="center" style="background:#DCDCDC;" |Additional findings
|-
|-
Line 170: Line 173:
! align="center" style="background:#DCDCDC;" |Thyroglobin
! align="center" style="background:#DCDCDC;" |Thyroglobin
! align="center" style="background:#DCDCDC;" |TRH
! align="center" style="background:#DCDCDC;" |TRH
! align="center" style="background:#DCDCDC;" |[[C-peptide]] level
! align="center" style="background:#DCDCDC;" |Anti TPO
! align="center" style="background:#DCDCDC;" |Serum [[glucagon]]
|-
|-
| colspan="2" style="background:#DCDCDC;" |Primary hypothyroidism
| rowspan="2" style="background:#DCDCDC;" |Primary hypothyroidism
|Hashimoto
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
Line 185: Line 188:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''''''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''''''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Auto antibodies present
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Auto antibodies present
([[GAD65|Anti GAD-65]] and anti insulin anti bodies)
([[GAD65|Anti GAD-65]] and anti insulin anti bodies)
|-
|Non-authoimmune
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
| colspan="2" style="background:#DCDCDC;" |Transient hypothyroidism
| colspan="2" style="background:#DCDCDC;" |Transient hypothyroidism
Line 203: Line 220:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Acanthosis nigricans]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Acanthosis nigricans]]
|-
|-
Line 219: Line 235:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
|-
|-
Line 236: Line 251:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | Other hormonal deficiencies
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
|-
|-
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |Hypothalamus
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |Hypothalamus
Line 248: Line 262:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |↓
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |↓
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
|-
|-
| colspan="2" style="background:#DCDCDC;" |Transient [[hyperglycemia]]
| colspan="2" style="background:#DCDCDC;" |Resistance to thyroid hormone
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
Line 265: Line 278:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |In hospitalized patients especially in [[ICU]] and [[CCU]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |In hospitalized patients especially in [[ICU]] and [[CCU]]
|-
|-
Line 280: Line 292:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Acanthosis nigricans|Acanthosis nigricans,]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Acanthosis nigricans|Acanthosis nigricans,]]
|-
|-
| colspan="2" style="background:#DCDCDC;" |[[RTA|RTA 1]]
| style="background:#DCDCDC;" |[[RTA|RTA 1]]
|
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
Line 295: Line 307:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Hypokalemia]], [[nephrolithiasis]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Hypokalemia]], [[nephrolithiasis]]
|-
|-
| colspan="2" style="background:#DCDCDC;" |[[Glucagonoma]]
| style="background:#DCDCDC;" |[[Glucagonoma]]
|
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
Line 313: Line 325:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Necrolytic migratory erythema]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Necrolytic migratory erythema]]
|-
|-
| colspan="2" style="background:#DCDCDC;" |[[Cushing's syndrome|Cushing syndrome]]
| style="background:#DCDCDC;" |[[Cushing's syndrome|Cushing syndrome]]
|
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
Line 328: Line 340:
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Moon face]], [[obesity]], [[buffalo hump]], easy [[Bruising|bruisibility]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Moon face]], [[obesity]], [[buffalo hump]], easy [[Bruising|bruisibility]]

Revision as of 14:55, 11 July 2017


For patient information click here

Hypothyroidism Main page

Patient Information

Overview

Classification

Primary hypothyroidism
Hashimoto's thyroiditis
Secondary hypothyroidism
Tertiary hypothyroidism

Differentiating different causes of hypothyroidism

Screening

Diagnosis

History and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]

Synonyms and keywords: Myxedema; myxoedema; thyroid activity decreased; hypothyroid

Overview

Classification

Origin of the defect Causes
Endagenous causes Exagenous causes
Thyroid Pituirtary Hypothalamus Surgery or radiation Other causes
Primary hypothyroidism + - -
  • Congenital hypothyroidism
  • Autoimmune (Hashimoto's) thyroiditis
  • Resistance to TSH
  • Thyroidectomy
  • Radioiodine therapy
  • Iodine deficeincy
  • Drug induced thyroiditis
    • Amiodarone
    • Lithium
    • Thionamide
    • Iodine
    • Iterferon
    • Sunitinib
    • Rifampicin
    • Thalidomide
Transient hypothyroidism + + -
  • Subacute (de Quervain’s) thyroiditis
  • Postpartum thyroiditis
  • Major suegeries
Central Hypothyroidism Secondary

OR

Pituitary originated

- + -
  • Pituitary mass lesions, especially pituitary adenomas
  • Brain cysts and abscesses
  • meningiomas
  • dysgerminomas
  • metastatic tumors
  • craniopharyngiomas
  • pituitary apoplexy
  • Sheehan syndrome (postpartum pituitary necrosis)
  • Idiopathic isolated TSH deficiency
  • surgery of pituitary adenomas
  • radiation therapy
    • pituitary adenomas
    • other mass lesions near pituitary gland
  • head trauma with injury of the stalk
Tertiary

OR

Hypothalamus originated

- - +
  • hemochromatosis
  • histiocytosis
  • autoimmune lymphocytic hypophysitis
  • Developmental abnormalities
  • internal carotid aneurysms
  • Other central nervous system (CNS) tumors
  • Idiopathic isolated TRH deficiency
  • Radiation in high doses to the
    • brain
    • infratemporal
    • nasopharyngeal
    • oropharyngeal
  • Infections
    • tuberculosis
    • syphilis
    • toxoplasmosis
  • sarcoidosis

hei

  • Primary hypothyroidism
    • Congenital hypothyroidism
    • Autoimmune (Hashimoto's) thyroiditis
    • Iodine deficeincy
    • Drug induced thyroiditis
      • Amiodarone
      • Lithium
      • Thionamide
      • Iodine
      • Iterferon
      • Sunitinib
      • Rifampicin
      • Thalidomide
    • Thyroidectomy
    • Radioiodine therapy
  • Transient hypothyroidism
    • Subacute (de Quervain’s) thyroiditis
    • Postpartum thyroiditis
  • Secondary hypothyroidism (due to decreased levels of TSH)
    • Pituitary mass lesions, especially pituitary adenomas
    • cysts and abscesses
    • meningiomas
    • dysgerminomas
    • metastatic tumors
    • craniopharyngiomas
    • surgery or radiation therapy for pituitary adenomas or other mass lesions near pituitary gland
    • head trauma with injury of the stalk
    • pituitary apoplexy
    • Sheehan syndrome (postpartum pituitary necrosis)
    • Idiopathic isolated TSH deficiency
  • Tertiary hypothyroidism
    • Infiltrative disorders affecting the pituitary or the hypothalamus include hemochromatosis, and histiocytosis
    • autoimmune lymphocytic hypophysitis
    • Developmental abnormalities
    • internal carotid aneurysms
    • Other central nervous system (CNS) tumors
    • Idiopathic isolated TRH deficiency

Differential diagnosis

Disease History and symptoms Laboratory findings Additional findings
Fever Goiter TSH Free T4 T3 T3RU Thyroglobin TRH Anti TPO
Primary hypothyroidism Hashimoto + + + + - Normal or ↓ Normal N/ Normal Auto antibodies present

(Anti GAD-65 and anti insulin anti bodies)

Non-authoimmune
Transient hypothyroidism + + + + - Normal Normal Normal Normal Acanthosis nigricans
Subclinical hypothyroidism + + + - + Normal Normal Normal Normal Normal -
Central Hypothyroidism Pituitary + + - - - Normal or ↓ Normal or ↓ Normal or ↓ Normal Normal Normal Other hormonal deficiencies
Hypothalamus + + - - - Normal Normal -
Resistance to thyroid hormone - - - - - Normal Normal Normal Normal In hospitalized patients especially in ICU and CCU
Steroid therapy + - - - + Normal Normal N/ Acanthosis nigricans,
RTA 1 - - - + - Normal Normal Normal Normal Normal Hypokalemia, nephrolithiasis
Glucagonoma - - - - - Normal Normal Normal - Normal Normal Necrolytic migratory erythema
Cushing syndrome - - - - + - Normal N/ Normal Moon face, obesity, buffalo hump, easy bruisibility

General feature

Symptoms

Constituitional Local Reproductive Neuropsysiological Others Physical exam
cold intolerance

puffiness

decreased sweating

coarse skin

hypothermia

Fever if accompanied by thyroiditis

weight gain

coarse, brittle, straw like hair with hair loss

obstructive sleep apnea (secondary to macroglossia) Females can present with galactorrhea and menstrual disturbances depression paresthesia and nerve entrapment syndromes decreased systolic blood pressure

increased diastolic blood pressure

bradycardia

pericardial effusion

abdominal distension

ascites (uncommon)

non-pitting edema (myxedema)

pitting edema of lower extremities

hyporeflexia with delayed relaxation

ataxia

fullness and pain in the throat and neck infertility emotional lability constipation
  • hoarseness
  • sore throat
blurred vision macroglossia
goiter Attention deficit periorbital puffiness
slowed speech and movements
  • Metabolic abnormalities associated with hypothyroidism include:
    • anemia,
    • dilutional hyponatremia,
    • hyperlipidemia,
    • reversible increase in creatinine

Complications

Myxedema coma

Rare, severe form of hypothyroidism, a life-threatening condition

  • Altered mental status,
  • hypothermia,
  • bradycardia,
  • hypercarbia, and
  • hyponatremia.
  • Cardiomegaly,
  • pericardial effusion,
  • cardiogenic shock, and
  • ascites
  • commonly occurs in individuals with undiagnosed or untreated hypothyroidism who is subjected to an external stress, such as low temperature, infection, or medical intervention (e.g., surgery or hypnotic drugs)

Screening

Diagnosis

Treatment

Prevention